Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?

Mills KA, Lopez H, Sun L, Cripe JC, Litz T, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Gynecol Oncol Rep. 2019 May 23;29:20-24. doi: 10.1016/j.gore.2019.05.007. eCollection 2019 Aug.

2.

Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?

Liang B, Lange SS, Massad LS, Dick R, Mills KA, Hagemann AR, McCourt CK, Thaker PH, Fuh KC, Mutch DG, Powell MA, Kuroki LM.

Gynecol Oncol Rep. 2019 Apr 24;28:136-140. doi: 10.1016/j.gore.2019.04.007. eCollection 2019 May.

3.

Oxytocin in the tumor microenvironment is associated with lower inflammation and longer survival in advanced epithelial ovarian cancer patients.

Cuneo MG, Szeto A, Schrepf A, Kinner EM, Schachner BI, Ahmed R, Thaker PH, Goodheart M, Bender D, Cole SW, McCabe PM, Sood AK, Lutgendorf SK, Mendez AJ.

Psychoneuroendocrinology. 2019 Aug;106:244-251. doi: 10.1016/j.psyneuen.2019.04.007. Epub 2019 Apr 6.

PMID:
31005045
4.

Wound Complication Rates After Vulvar Excisions for Premalignant Lesions.

Mullen MM, Merfeld EC, Palisoul ML, Massad LS, Woolfolk C, Powell MA, Mutch DG, Thaker PH, Hagemann AR, Kuroki LM.

Obstet Gynecol. 2019 Apr;133(4):658-665. doi: 10.1097/AOG.0000000000003185.

PMID:
30870300
5.

GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.

Brooks RA, Tritchler DS, Darcy KM, Lankes HA, Salani R, Sperduto P, Guntupalli S, DiSilvestro P, Kesterson J, Olawaiye AB, Moxley K, Waggoner S, Santin A, Rader JS, Kizer NT, Thaker PH, Powell MA, Mutch DG, Birrer MJ, Goodfellow PJ.

Gynecol Oncol. 2019 May;153(2):335-342. doi: 10.1016/j.ygyno.2019.02.028. Epub 2019 Feb 28.

6.

Continuous epidural infusion in gynecologic oncology patients undergoing exploratory laparotomy: The new standard for decreased postoperative pain and opioid use.

Huepenbecker SP, Cusworth SE, Kuroki LM, Lu P, Samen CDK, Woolfolk C, Deterding R, Wan L, Helsten DL, Bottros M, Mutch DG, Powell MA, Massad LS, Thaker PH.

Gynecol Oncol. 2019 May;153(2):356-361. doi: 10.1016/j.ygyno.2019.02.017. Epub 2019 Feb 22.

PMID:
30798950
7.

Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care?

Cripe JC, Buchanan TR Jr, Wan L, Hagemann AR, McCourt CK, Massad LS, Fuh KC, Mutch DG, Powell MA, Thaker PH, Kuroki LM.

Gynecol Oncol Rep. 2019 Jan 26;28:1-5. doi: 10.1016/j.gore.2019.01.005. eCollection 2019 May.

8.

Palliative Care in Gynecologic Oncology.

Mullen MM, Cripe JC, Thaker PH.

Obstet Gynecol Clin North Am. 2019 Mar;46(1):179-197. doi: 10.1016/j.ogc.2018.10.001. Review.

PMID:
30683263
9.

Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer.

Cripe JC, Buchanan TR Jr, Kuroki LM, Wan L, Mills KA, Massad L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Matsuo K, Thaker PH.

Gynecol Oncol. 2019 Apr;153(1):123-126. doi: 10.1016/j.ygyno.2019.01.009. Epub 2019 Jan 14.

PMID:
30651188
10.

Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.

Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, Zhao P, Beck-Noia H, Hagemann IS, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Mol Cancer Ther. 2019 Feb;18(2):389-398. doi: 10.1158/1535-7163.MCT-18-0537. Epub 2018 Nov 26.

PMID:
30478151
11.

Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.

Lin AJ, Kidd E, Dehdashti F, Siegel BA, Mutic S, Thaker PH, Massad LS, Powell MA, Mutch DG, Markovina S, Schwarz J, Grigsby PW.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1088-1097. doi: 10.1016/j.ijrobp.2018.11.012. Epub 2018 Nov 14.

PMID:
30445171
12.

Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review.

Mullen MM, Kuroki LM, Thaker PH.

Gynecol Oncol. 2019 Feb;152(2):416-425. doi: 10.1016/j.ygyno.2018.10.023. Epub 2018 Nov 5. Review.

PMID:
30409489
13.

GEN-1 immunotherapy for the treatment of ovarian cancer.

Thaker PH, Borys N, Fewell J, Anwer K.

Future Oncol. 2019 Feb;15(4):421-438. doi: 10.2217/fon-2018-0423. Epub 2018 Oct 16.

PMID:
30325199
14.

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.

Hensley ML, Enserro D, Hatcher H, Ottevanger PB, Krarup-Hansen A, Blay JY, Fisher C, Moxley KM, Lele SB, Lea JS, Tewari KS, Thaker PH, Zivanovic O, O'Malley DM, Robison K, Miller DS.

J Clin Oncol. 2018 Oct 5:JCO1800454. doi: 10.1200/JCO.18.00454. [Epub ahead of print]

PMID:
30289732
15.

SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth.

Mills KA, Roach ST, Quinn JM, Guo L, Beck HM, Lomonosova E, Ilivicky AR, Starks CM, Lawrence JA, Hagemann AR, McCourt C, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Gynecol Oncol. 2018 Nov;151(2):337-344. doi: 10.1016/j.ygyno.2018.08.008. Epub 2018 Sep 3.

16.

Gynecologic Oncologists' Perceptions of Palliative Care and Associated Barriers: A Survey of the Society of Gynecologic Oncology.

Cripe JC, Mills KA, Kuroki LK, Wan L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Thaker PH.

Gynecol Obstet Invest. 2019;84(1):50-55. doi: 10.1159/000491089. Epub 2018 Aug 10. Review.

PMID:
30099446
17.

Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Cohn DE, Brasky TM, Zaino R, Park K, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Randall ME, Brinton LA.

Am J Obstet Gynecol. 2018 Nov;219(5):459.e1-459.e11. doi: 10.1016/j.ajog.2018.08.002. Epub 2018 Aug 7.

PMID:
30096321
18.

Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.

Armer JS, Clevenger L, Davis LZ, Cuneo M, Thaker PH, Goodheart MJ, Bender DP, Dahmoush L, Sood AK, Cole SW, Slavich GM, Lutgendorf SK.

Cancer. 2018 Aug;124(16):3401-3408. doi: 10.1002/cncr.31570. Epub 2018 Jun 15.

PMID:
29905941
19.

A rare case of endometrial cancer metastatic to the uveal choroid.

Smith SH, Arudra SKC, Mullen MM, Palisoul M, Dahiya S, Kumar Rao P, Thaker PH.

Gynecol Oncol Rep. 2018 Jan 4;23:24-27. doi: 10.1016/j.gore.2018.01.001. eCollection 2018 Feb.

20.

Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.

Lutgendorf SK, Thaker PH, Arevalo JM, Goodheart MJ, Slavich GM, Sood AK, Cole SW.

Cancer. 2018 Feb 1;124(3):580-586. doi: 10.1002/cncr.31078. Epub 2017 Nov 7.

21.

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Brasky TM, Cohn DE, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel C, Boggess JF, Pearl ML, Ioffe OB, Deng W, Miller DS, Brinton LA.

Int J Cancer. 2018 Mar 15;142(6):1102-1115. doi: 10.1002/ijc.31127. Epub 2017 Nov 6.

22.

Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.

Binder PS, Kuroki LM, Zhao P, Cusworth S, Divine LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Massad LS.

Gynecol Oncol. 2017 Nov;147(2):309-314. doi: 10.1016/j.ygyno.2017.08.031. Epub 2017 Sep 13.

PMID:
28916118
23.

Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.

Palisoul ML, Quinn JM, Schepers E, Hagemann IS, Guo L, Reger K, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Mol Cancer Ther. 2017 Dec;16(12):2881-2891. doi: 10.1158/1535-7163.MCT-17-0587. Epub 2017 Sep 13.

24.
25.

The effect of a multidisciplinary palliative care initiative on end of life care in gynecologic oncology patients.

Mullen MM, Divine LM, Porcelli BP, Wilkinson-Ryan I, Dans MC, Powell MA, Mutch DG, Hagemann AR, Thaker PH.

Gynecol Oncol. 2017 Nov;147(2):460-464. doi: 10.1016/j.ygyno.2017.08.002. Epub 2017 Aug 4.

PMID:
28784245
26.

Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancer.

Cuneo MG, Schrepf A, Slavich GM, Thaker PH, Goodheart M, Bender D, Cole SW, Sood AK, Lutgendorf SK.

Psychoneuroendocrinology. 2017 Oct;84:139-142. doi: 10.1016/j.psyneuen.2017.06.019. Epub 2017 Jun 30.

27.

Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer.

Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman LD, Wright JD.

Obstet Gynecol. 2017 Aug;130(2):403-410. doi: 10.1097/AOG.0000000000002142.

PMID:
28697110
28.

Yield of Cytology Surveillance After High-Grade Vulvar Intraepithelial Neoplasia or Cancer.

Kuroki LM, Frolova AI, Wu N, Liu J, Powell M, Thaker PH, Massad LS.

J Low Genit Tract Dis. 2017 Jul;21(3):193-197. doi: 10.1097/LGT.0000000000000321.

29.

Changes in spiritual well-being and psychological outcomes in ovarian cancer survivors.

Davis LZ, Cuneo M, Thaker PH, Goodheart MJ, Bender D, Lutgendorf SK.

Psychooncology. 2018 Feb;27(2):477-483. doi: 10.1002/pon.4485. Epub 2017 Aug 4.

30.

Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model.

Budiu RA, Vlad AM, Nazario L, Bathula C, Cooper KL, Edmed J, Thaker PH, Urban J, Kalinski P, Lee AV, Elishaev EL, Conrads TP, Flint MS.

Cancer Clin Oncol. 2017 May;6(1):12-24. doi: 10.5539/cco.v6n1p12. Epub 2016 Nov 11.

31.

Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled Trial.

Kuroki LM, Mullen MM, Massad LS, Wu N, Liu J, Mutch DG, Powell MA, Hagemann AR, Thaker PH, McCourt CK, Novetsky AP.

Obstet Gynecol. 2017 Jul;130(1):91-99. doi: 10.1097/AOG.0000000000002061.

32.

Identification of molecular targets in vulvar cancers.

Palisoul ML, Mullen MM, Feldman R, Thaker PH.

Gynecol Oncol. 2017 Aug;146(2):305-313. doi: 10.1016/j.ygyno.2017.05.011. Epub 2017 May 20.

PMID:
28536037
33.

Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.

Ioffe YJ, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH, Schwarz JK, Grigsby PW.

Gynecol Obstet Invest. 2018;83(1):83-89. doi: 10.1159/000458706. Epub 2017 Apr 8.

PMID:
28399524
34.

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.

Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-10. doi: 10.1093/jnci/djw251.

35.

A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.

Rader JS, Sill MW, Beumer JH, Lankes HA, Benbrook DM, Garcia F, Trimble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA 3rd, Spirtos NM, Byron J, Thaker PH, Lele S, Alberts D.

Gynecol Oncol. 2017 May;145(2):291-297. doi: 10.1016/j.ygyno.2017.02.040. Epub 2017 Mar 10.

36.

Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients.

Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM.

Support Care Cancer. 2017 Jun;25(6):1985-1991. doi: 10.1007/s00520-017-3605-z. Epub 2017 Feb 7.

37.

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).

Thaker PH, Salani R, Brady WE, Lankes HA, Cohn DE, Mutch DG, Mannel RS, Bell-McGuinn KM, Di Silvestro PA, Jelovac D, Carter JS, Duan W, Resnick KE, Dizon DS, Aghajanian C, Fracasso PM.

Ann Oncol. 2017 Mar 1;28(3):505-511. doi: 10.1093/annonc/mdw635.

38.

Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and Recommendations.

Cass I, Duska LR, Blank SV, Cheng G, duPont NC, Frederick PJ, Hill EK, Matthews CM, Pua TL, Rath KS, Ruskin R, Thaker PH, Berchuck A, Gostout BS, Kushner DM, Fowler JM.

Gynecol Oncol. 2016 Nov;143(2):421-427. doi: 10.1016/j.ygyno.2016.08.319. Epub 2016 Aug 27. Review. No abstract available.

PMID:
27575910
39.

AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer.

Divine LM, Nguyen MR, Meller E, Desai RA, Arif B, Rankin EB, Bligard KH, Meyerson C, Hagemann IS, Massad M, Thaker PH, Hagemann AR, McCourt CK, Powell MA, Mutch DG, Fuh KC.

Oncotarget. 2016 Nov 22;7(47):77291-77305. doi: 10.18632/oncotarget.12637.

40.

Reply.

Binder PS, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK, Peipert JF, Kallogjeri D, Brooks RA.

Am J Obstet Gynecol. 2017 Feb;216(2):192-193. doi: 10.1016/j.ajog.2016.09.084. Epub 2016 Sep 15. No abstract available.

PMID:
27640937
41.

High-Grade Cervical Dysplasia After Negative Loop Electrosurgical Excision Procedure.

Kuroki LM, James-Nywening L, Wu N, Liu J, Powell MA, Thaker PH, Massad LS.

J Low Genit Tract Dis. 2016 Oct;20(4):300-6. doi: 10.1097/LGT.0000000000000260.

42.

Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.

Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK.

Am J Obstet Gynecol. 2016 Dec;215(6):766.e1-766.e9. doi: 10.1016/j.ajog.2016.07.035. Epub 2016 Jul 22.

43.

See-and-Treat Loop Electrosurgical Excision Procedure for High-Grade Cervical Cytology: Are We Overtreating?

Kuroki LM, Bergeron LM, Gao F, Thaker PH, Massad LS.

J Low Genit Tract Dis. 2016 Jul;20(3):247-51. doi: 10.1097/LGT.0000000000000230.

44.

SSRI use and clinical outcomes in epithelial ovarian cancer.

Christensen DK, Armaiz-Pena GN, Ramirez E, Matsuo K, Zimmerman B, Zand B, Shinn E, Goodheart MJ, Bender D, Thaker PH, Ahmed A, Penedo FJ, DeGeest K, Mendez L, Domann F, Sood AK, Lutgendorf SK.

Oncotarget. 2016 May 31;7(22):33179-91. doi: 10.18632/oncotarget.8891.

45.

Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Divine LM, Kizer NT, Hagemann AR, Pittman ME, Chen L, Powell MA, Mutch DG, Rader JS, Thaker PH.

Gynecol Oncol. 2016 Jul;142(1):76-82. doi: 10.1016/j.ygyno.2016.04.030. Epub 2016 May 8.

46.

Reply to beta blockers in epithelial ovarian cancer and beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?

Thaker PH, Urbauer DL, Sood AK.

Cancer. 2016 Jan 15;122(2):325-6. doi: 10.1002/cncr.29723. Epub 2015 Oct 7. No abstract available.

47.

Postmenopausal Invasive Endometriosis Requiring Supralevator Pelvic Exenteration.

Klenov VE, Potretzke TA, Sehn JK, Thaker PH.

Obstet Gynecol. 2015 Dec;126(6):1215-8. doi: 10.1097/AOG.0000000000000998.

PMID:
26375714
48.

Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.

Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, Matsuo K, Squires KC, Coleman RL, Lutgendorf SK, Ramirez PT, Sood AK.

Cancer. 2015 Oct 1;121(19):3444-51. doi: 10.1002/cncr.29392. Epub 2015 Aug 24.

49.

Chemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets.

Kizer NT, Hatem H, Nugent EK, Zhou G, Moore K, Heller P, Mutch DG, Thaker PH.

Int J Gynecol Cancer. 2015 Jul;25(6):1015-22. doi: 10.1097/IGC.0000000000000453.

50.

Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.

Davis LZ, Slavich GM, Thaker PH, Goodheart MJ, Bender DP, Dahmoush L, Farley DM, Markon KE, Penedo FJ, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Cancer. 2015 Oct 1;121(19):3543-50. doi: 10.1002/cncr.29516. Epub 2015 Jun 10.

Supplemental Content

Loading ...
Support Center